title: Rhabdomyolysis caused by distigmine bromide.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tsutsumi
authors.forename: Junji
authors.initials: J
authors.lastname: Tanaka
authors.forename: Takuya
authors.initials: T
authors.lastname: Miura
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Yamato
authors.forename: Hiroe
authors.initials: H
authors.lastname: Kanamori
authors.forename: Takahito
authors.initials: T
authors.lastname: Kawamura
authors.forename: Shinji
authors.initials: S
authors.lastname: Obara
authors.forename: Masahiro
authors.initials: M
authors.lastname: Asaka
authors.forename: Masahiro
authors.initials: M
authors.lastname: Imamura
authors.forename: Nobuo
authors.initials: N
authors.lastname: Masauzi
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects; D002792:Cholestyramine Resin / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D006801:Humans; D018482:Muscle, Skeletal / Q000187:drug effects*; D017035:Pravastatin / Q000009:adverse effects; D011726:Pyridinium Compounds / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis; D016055:Urinary Retention / Q000188:drug therapy
chemical_list: D000924:Anticholesteremic Agents; D011726:Pyridinium Compounds; D002792:Cholestyramine Resin; D017035:Pravastatin; C084645:distigmine